JP2022541311A5 - - Google Patents

Info

Publication number
JP2022541311A5
JP2022541311A5 JP2022504089A JP2022504089A JP2022541311A5 JP 2022541311 A5 JP2022541311 A5 JP 2022541311A5 JP 2022504089 A JP2022504089 A JP 2022504089A JP 2022504089 A JP2022504089 A JP 2022504089A JP 2022541311 A5 JP2022541311 A5 JP 2022541311A5
Authority
JP
Japan
Prior art keywords
hydroxy
compound
carboxamide
acetyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022504089A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541311A (ja
JP7583022B2 (ja
Filing date
Publication date
Priority claimed from GBGB1910607.9A external-priority patent/GB201910607D0/en
Priority claimed from GBGB2005739.4A external-priority patent/GB202005739D0/en
Application filed filed Critical
Priority claimed from PCT/GB2020/051778 external-priority patent/WO2021014166A1/en
Publication of JP2022541311A publication Critical patent/JP2022541311A/ja
Publication of JP2022541311A5 publication Critical patent/JP2022541311A5/ja
Application granted granted Critical
Publication of JP7583022B2 publication Critical patent/JP7583022B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022504089A 2019-07-24 2020-07-24 呼吸器症状の治療における使用のためのtmem16aモジュレータとしてのピリジン誘導体 Active JP7583022B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1910607.9 2019-07-24
GBGB1910607.9A GB201910607D0 (en) 2019-07-24 2019-07-24 Compounds
GBGB2005739.4A GB202005739D0 (en) 2020-04-20 2020-04-20 Compounds
GB2005739.4 2020-04-20
PCT/GB2020/051778 WO2021014166A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions

Publications (3)

Publication Number Publication Date
JP2022541311A JP2022541311A (ja) 2022-09-22
JP2022541311A5 true JP2022541311A5 (enExample) 2023-07-25
JP7583022B2 JP7583022B2 (ja) 2024-11-13

Family

ID=71948615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022504089A Active JP7583022B2 (ja) 2019-07-24 2020-07-24 呼吸器症状の治療における使用のためのtmem16aモジュレータとしてのピリジン誘導体

Country Status (16)

Country Link
US (1) US20220235006A1 (enExample)
EP (1) EP4003516A1 (enExample)
JP (1) JP7583022B2 (enExample)
KR (1) KR20220063162A (enExample)
CN (1) CN114616226B (enExample)
AU (1) AU2020317036A1 (enExample)
BR (1) BR112022001164A2 (enExample)
CA (1) CA3145120A1 (enExample)
CL (1) CL2022000147A1 (enExample)
CO (1) CO2022002022A2 (enExample)
CR (1) CR20220072A (enExample)
IL (1) IL290035A (enExample)
MX (1) MX2022000841A (enExample)
PE (1) PE20221441A1 (enExample)
PH (1) PH12022550181A1 (enExample)
WO (1) WO2021014166A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220063162A (ko) * 2019-07-24 2022-05-17 티엠이엠16에이 리미티드 호흡기 병태 치료에 사용하기 위한 tmem16a 조절제로서의 피리딘 유도체
KR20260025059A (ko) * 2024-08-13 2026-02-23 전남대학교산학협력단 신규한 치환된 피리딘 유도체 화합물, 이의 제조방법, 및 이를 유효성분으로 포함하는 호흡기 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042524A1 (en) * 2003-10-30 2005-05-12 Virochem Pharma Inc. Pyridine carboxamide and methods for inhibiting hiv integrase
WO2018195127A1 (en) * 2017-04-17 2018-10-25 The Regents Of The University Of California Substituted 2-acylamino-cycloakylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel tmem16a
GB201801355D0 (en) * 2018-01-26 2018-03-14 Enterprise Therapeutics Ltd Compounds
KR20220063162A (ko) * 2019-07-24 2022-05-17 티엠이엠16에이 리미티드 호흡기 병태 치료에 사용하기 위한 tmem16a 조절제로서의 피리딘 유도체

Similar Documents

Publication Publication Date Title
US11993581B2 (en) Pyridazine compounds for inhibiting Nav1.8
AU2016202676B2 (en) Polycyclic antagonists of lysophosphatidic acid receptors
JP2024050527A5 (enExample)
JP2021512143A5 (enExample)
JP2004502670A5 (enExample)
JP2020125355A (ja) 併用療法
JP2006501295A5 (enExample)
FI3743406T3 (fi) Tmem16a-modulaattoreita
JP2014530900A5 (enExample)
DK2888239T3 (en) REDUCED CENTRAL CORCHET THICKENING USING HYDROFILE ESTER PRODUGS OF BETA-CHLORCYCLOPENTANE
JP2013531070A5 (enExample)
RU2013130879A (ru) Производные оксазолилметилового эфира в качестве агонистов рецептора alx
JP2023544716A5 (enExample)
JP2022541311A5 (enExample)
US12435040B2 (en) 1,3-substituted cyclobutyl derivatives and uses thereof
JP2024516826A5 (enExample)
JP2024161441A (ja) 呼吸器疾患の処理のための新規な化合物
JP2019530674A5 (enExample)
JP2017509694A5 (enExample)
JP2024509981A5 (enExample)
JP2020111571A5 (enExample)
JP2004524345A5 (enExample)
JP2025508071A5 (enExample)
JP2021530440A5 (enExample)
RU2016105158A (ru) Соединения мочевины и их применение в качестве ингибиторов гидролазы амидов жирных кислот